Eczema Awareness Monthly – An American Academy of Dermatology Official Licensee
0
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
0
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Advertisement
EczemaStudies

Alleviating itch and improving quality of life in patients with atopic dermatitis

Awareness Monthly
Posted by Awareness Monthly

A random study was conducted and reported on the effects of ruxolitinib cream on pruritis and QoL in patients with atopic dermatitis.

Learn more at the Journal of the American Academy of Dermatology

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Awareness Monthly
Previous Article Evaluating the long-term efficacy, safety, and discontinuation of dupilumab on atopic dermatitis
Next Article Assessing the effectiveness of delgocitinib ointment on atopic dermatitis

Leave a Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

 

Advertisement

 

You Might Also Enjoy

ArticlesEczema

First Topical JAK Inhibitor for Atopic Dermatitis Receives FDA Approval

ArticlesEczema

Pediatric Atopic Dermatitis: Topical Calcineurin Inhibitors

ArticlesEczema

Atopic Dermatitis and COVID-19 Infection Risk

ArticlesEczema

Biologic for Atopic Dermatitis FDA Approved

Load More
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee

© 2020-2023 Powered by eHealthcare Solutions | Privacy Policy

×